ACTUM I, LLC

Lobbying for PRIO PHARMA, INC. · pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $10,000.00 income · posted Jul 20, 2025

Lobbying activity 2

Budget/Appropriations

FY26 Defense Appropriations bill - Defense Health Program funding; FY25 Continuing Resolution (P.L. 119-4)

Defense

FY26 Defense Appropriations bill - Defense Health Program funding; FY26 National Defense Authorization Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.